We are live on
!
Find out more
RC
Rovin Capital Portfolio holdings
AUM
$377M
1-Year Est. Return
13.67%
This Fund
S&P 500
This Quarter
Est. Return
-1.76%
1 Year Est. Return
+13.67%
3 Year Est. Return
+63.79%
5 Year Est. Return
+64.65%
10 Year Est. Return
–
AUM
$311M
AUM Growth
+$32.9M
(+12%)
Cap. Flow
+$42.3M
Cap. Flow
% of AUM
13.62%
Top 10 Holdings %
Top 10 Hldgs %
38.29%
Holding
189
New
27
Increased
85
Reduced
53
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DaVita
DVA
|
+$18.9M |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$8.95M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$8.44M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$5.98M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$5.42M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Bloomberg High Yield Bond ETF
JNK
|
+$8.26M |
| 2 |
Invesco NASDAQ 100 ETF
QQQM
|
+$6.9M |
| 3 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$6.88M |
| 4 |
iShares S&P Small-Cap 600 Growth ETF
IJT
|
+$6.73M |
| 5 |
iShares S&P Small-Cap 600 Value ETF
IJS
|
+$6.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 8.28% |
| 2 | Technology | 5.75% |
| 3 | Financials | 1.57% |
| 4 | Consumer Staples | 1.54% |
| 5 | Communication Services | 1.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Compass Therapeutics
CMPX
$349M
| $26K | 0.01% |
13,495
| – | – |
|
|
ONCY
177
Oncolytics Biotech
ONCY
$89.9M
| $11K | ﹤0.01% |
20,620
| – | – |
|
178
Air Products & Chemicals
APD
$66.8B
| – | – |
-850
| Closed | -$247K |
|
179
Bio-Rad Laboratories Class A
BIO
$8.74B
| – | – |
-1,667
| Closed | -$548K |
|
180
Blackrock
BLK
$170B
| – | – |
-292
| Closed | -$299K |
|
181
Emerson Electric
EMR
$83.3B
| – | – |
-3,278
| Closed | -$406K |
|
182
Honeywell
HON
$76.7B
| – | – |
-1,528
| Closed | -$325K |
|
183
IDEX
IEX
$17.3B
| – | – |
-1,258
| Closed | -$263K |
|
184
iShares Core S&P Mid-Cap ETF
IJH
$122B
| – | – |
-3,249
| Closed | -$202K |
|
185
iShares Core S&P Small-Cap ETF
IJR
$110B
| – | – |
-8,681
| Closed | -$1M |
|
186
Masco
MAS
$14.2B
| – | – |
-3,696
| Closed | -$268K |
|
187
Otis Worldwide
OTIS
$27.3B
| – | – |
-2,709
| Closed | -$251K |
|
188
Invesco S&P 500 Equal Weight Industrials ETF
RSPN
$1.07B
| – | – |
-4,637
| Closed | -$231K |
|
|
QQQH
189
NEOS Nasdaq-100 Hedged Equity Income ETF
QQQH
$373M
| – | – |
-21,902
| Closed | -$1.14M |
|
Similar funds
PWM
EP
RPCA
DP
PPL
MWM
LODC
AWIRL
Rovin Capital's Q1 2025 Portfolio in Review
As of Q1 2025, Rovin Capital held 189 positions worth $311M, up 12% from $278M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Rovin Capital deployed $42.3M of net new capital in Q1 2025, opening 27 new positions and adding to 85 existing holdings. Its largest new stake was DaVita: 120,562 shares worth $18.4M.
By sector, the portfolio is most concentrated in Healthcare at 8.3% of assets, up from 2.2% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR Bloomberg High Yield Bond ETF, an estimated $8.26M trimmed.
- Rovin Capital's largest Q1 2025 buy was DaVita: 120,562 shares worth $18.4M.
- Rovin Capital added most to iShares Core MSCI Emerging Markets ETF in Q1 2025, an estimated $8.95M increase.
- Rovin Capital's biggest Q1 2025 reduction was State Street SPDR Bloomberg High Yield Bond ETF, cutting an estimated $8.26M.
- Rovin Capital fully exited NEOS Nasdaq-100 Hedged Equity Income ETF in Q1 2025, selling an estimated $1.14M.
- Rovin Capital's ten largest holdings make up 38% of its $311M portfolio in Q1 2025.
- Rovin Capital opened 27 new positions and closed 12 in Q1 2025.
- Rovin Capital's portfolio value rose 12% quarter-over-quarter to $311M.
Based on Rovin Capital's 13F filing for Q1 2025, filed 28 Apr 2025.